APGE Latest Press Releases

-- November 10, 2025 --

Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results Globe Newswire 7:10 AM

Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody Globe Newswire 7:00 AM

-- November 3, 2025 --

Apogee Therapeutics to Participate in Upcoming Conferences Globe Newswire 7:30 AM

-- October 10, 2025 --

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $345 Million Globe Newswire 4:01 PM

-- October 8, 2025 --

Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering Globe Newswire 9:52 PM

Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering Globe Newswire 4:01 PM

-- September 11, 2025 --

Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress Globe Newswire 7:30 AM

-- September 3, 2025 --

Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum Globe Newswire 7:30 AM

-- August 11, 2025 --

Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software